Clinical Trials Directory

Trials / Conditions / Nonvalvular Atrial Fibrillation

Nonvalvular Atrial Fibrillation

14 registered clinical trials studyying Nonvalvular Atrial Fibrillation — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingApixaban Safety and Therapy Adherence in Patients With Atrial Fibrillation
NCT07458191
Bosnalijek D.D—
RecruitingNon-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure
NCT07125417
OCEAN-SHD Study GroupPhase 4
UnknownPharmacokinetic Study to Evaluate Dabigatran Etexilate in Elderly Subjects
NCT05715658
Dongyang LiuN/A
UnknownFirst in Man Study of Left Atrial Appendage Pulsed Field Ablation Occluder
NCT05731882
Hangzhou Dinova EP Technology Co., LtdN/A
UnknownThe Adherence to Oral Anticoagulant in Chinese Patients With NVAF
NCT04942873
Second Affiliated Hospital, School of Medicine, Zhejiang University—
RecruitingWatchman for Patients With Atrial Fibrillation Undergoing Transcatheter Mitral Valve Repair (WATCH-TMVR)
NCT04494347
Mayo ClinicN/A
CompletedSafety and Efficacy of Apixaban in Very Old Geriatric Subjects (> 80 Years) With Atrial FIbrillation in a Pros
NCT04586972
Gérond'if—
UnknownAntiCoagulants and COGnition
NCT04073316
University Hospital, AngersPhase 4
CompletedRivaroxaban vs Warfarin for SPAF in Multi-morbid Patients
NCT03374540
Bayer—
CompletedBenchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation
NCT02919982
Baim Institute for Clinical Research—
CompletedEvaluation of Hospital Readmissions Among Hospitalized Non-valvular Atrial Fibrillation (NVAF) Patients in the
NCT02674594
Bristol-Myers Squibb—
CompletedEliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation
NCT02007655
Bristol-Myers Squibb—
CompletedEliquis Regulatory Post Marketing Surveillance
NCT01885598
Bristol-Myers Squibb—
CompletedPrevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation
NCT00684307
AstraZenecaPhase 2